NCT03645408View on ClinicalTrials.gov

The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions
Alcohol Use Disorder
Interventions
DRUG

Exenatide

Subject received an injection of 5 mcg of immediate release exenatide.

OTHER

Sham injection

Subjects received a sham injection with no study drug.

Trial Locations (1)

02118

Boston University Psychiatry Research Center, Clinical Studies Unit, Boston

Sponsors
All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Boston Medical Center

OTHER

NCT03645408 - The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers | Biotech Hunter | Biotech Hunter